Form 4 for KURA Kura Oncology, Inc.
Accepted 2022-02-09 00:00:00 ET · period of report 2022-02-07 · accession 0001209191-22-008156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-09 | 2022-02-07 | KURA | DOYLE THOMAS JAMES | SVP, Fin, Accounting | A - Grant | $0.00 | +8,390 | 15.0K | +127% | $0 |
| D | 2022-02-09 | 2022-02-07 | KURA | DOYLE THOMAS JAMES | SVP, Fin, Accounting | A - Grant | $0.00 | +39.3K | 39.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-07 | A | A | 8,390 | $0.00 | 15,000 | D | — | — | (F1) Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26. |
| 2 | Derivative | Option to purchase common stock | 2022-02-07 | A | A | 39,281 | $0.00 | 39,281 | D | $13.14 · — to 2032-02-06 | 39,281 Common Stock | (F2) This option vests in 48 equal monthly installments commencing on the grant date. |